Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292586 · ClinicalTrials.gov registry record · Phase 3
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
A Phase 3 study of Asthma, sponsored by Chiesi Farmaceutici S.p.A..
- Completed
- Registry status
- Phase 3
- Development phase
- 1,377
- Enrollment target
- 20
- Study locations
NCT05292586 is a Phase 3 study of Asthma that has completed, run by Chiesi Farmaceutici S.p.A.. The registered enrollment target is 1,377 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (12% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT05292586, a Phase 3 study of Asthma, has completed, sponsored by Chiesi Farmaceutici S.p.A..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,377 participants
- Enrollment target
- 20
- Study locations
Study Summary
Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.
Conditions Studied
Interventions
- DRUG Beclomethasone Dipropionate/Formoterol Fumarate
- DRUG Beclomethasone Dipropionate
Study Locations (20)
California
- Chiesi Clinical Trial Site 840856 - Encinitas
- Chiesi Clinical Trial Site 840843 - Huntington Beach
- Chiesi Clinical Trial Site 840860 - Huntington Beach
- Chiesi Clinical Trial Site 840896 - Long Beach
- Chiesi Clinical Trial Site 840883 - Los Angeles
- Chiesi Clinical Trial Site 840810 - Los Angeles
- Chiesi Clinical Trial Site 840869 - Newport Beach
- Chiesi Clinical Trial Site 840890 - North Hollywood
- Chiesi Clinical Trial Site 840808 - Northridge
- Chiesi Clinical Trial Site 840879 - Pomona
- Chiesi Clinical Trial Site 840868 - Sacramento
- Chiesi Clinical Trial Site 840849 - San Diego
- Chiesi Clinical Trial Site 840877 - San Diego
- Chiesi Clinical Trial Site 840861 - San Jose
- Chiesi Clinical Trial Site 840881 - Westminster
Colorado
- Chiesi Clinical Trial Site 840873 - Colorado Springs
- Chiesi Clinical Trial Site 840800 - Denver
Alabama
- Chiesi Clinical Trial Site 840858 - Mobile
Arizona
- Chiesi Clinical Trial Site 840895 - Chandler
Florida
- Chiesi Clinical Trial Site 840820 - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,377 participants |
| Start Date | 2022-08-31 |
| Est. Completion | 2024-06-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05292586
The ClinicalTrials.gov registry entry for NCT05292586 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,377 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (12% lower). The listed sponsor is Chiesi Farmaceutici S.p.A., which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Beclomethasone Dipropionate/Formoterol Fumarate is the first listed.
NCT05292586 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Alabama.
Frequently Asked Questions
What is clinical trial NCT05292586 about?
NCT05292586 is a clinical study titled "A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid". Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.
What is the current status of trial NCT05292586?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,377 participants. The study started on 2022-08-31. Estimated completion is 2024-06-24.
What conditions does trial NCT05292586 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT05292586?
The interventions under investigation include: Beclomethasone Dipropionate/Formoterol Fumarate (DRUG), Beclomethasone Dipropionate (DRUG).
Who is sponsoring clinical trial NCT05292586?
This trial is sponsored by Chiesi Farmaceutici S.p.A., which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292586 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RECRUITING · Phase 3
-
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
RECRUITING · Phase 3
-
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
RECRUITING · Phase 3
-
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.